Head and Neck Cancer

PV QA 2 - Poster Viewing Q&A 2

MO_32_2753 - Loco-regional relapse and predictors of outcome in early stage oral cavity cancers (pT1-2N0) treated with surgical monotherapy with or without neck dissection: a multi-institutional study

Monday, October 22
10:45 AM - 12:15 PM
Location: Innovation Hub, Exhibit Hall 3

Howard Liu, MD

Disclosure:
No relationships to disclose.

Biography:
Dr. Howard Liu, MD, FRANZCR, is a Staff Specialist in Radiation Oncology at the Princess Alexandra Hospital in Brisbane, Australia, and Senior Lecturer at the University of Queensland, Australia. He has a specialised interest in head and neck oncology, complex skin cancer management, stereotactic body radiation therapy and sarcoma. He was a co-author of the TROG 05.01 Post Operative Skin Trial publication in 2018 and is heavily involved in the head and neck oncology and liver stereotactic body radiation therapy research program at Princess Alexandra Hospital. Dr. Liu is the lead co-investigator of the Australian national liver SBRT database.

Presentation(s):

Send Email for Howard Liu


Assets

MO_32_2753 - Loco-regional relapse and predictors of outcome in early stage oral cavity cancers (pT1-2N0) treated with surgical monotherapy with or without neck dissection: a multi-institutional study



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Loco-regional relapse and predictors of outcome in early stage oral cavity cancers (pT1-2N0) treated with surgical monotherapy with or without neck dissection: a multi-institutional study